GO:0051978 lysophospholipid:sodium symporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051978 defines a molecular function that enables the sodium-dependent, directed movement of lysophospholipids across a membrane.
• Lysophospholipids such as lysophosphatidylcholine (LPC) and lysophosphatidylinositol (LPI) are bioactive lipids that modulate ion channels, transporters, and cell signaling.
• This transport activity is distinct from passive diffusion and is coupled to the sodium gradient, though direct molecular identity of the symporter remains under investigation.
• Lysophospholipid signaling intersects with disease processes including secretory diarrhea, polycystic kidney disease, and cardiac arrhythmias.
• Key research tools include knockout and point-mutation cell models, lipid flux assays, and electrophysiology to dissect symporter function.
• EDITGENE provides CRISPR knockout, knock-in, overexpression, and library screening services to study GO:0051978-related genes.
Description
GO:0051978, lysophospholipid:sodium symporter activity, is a molecular function that enables the directed movement of lysophospholipids from one side of a membrane to the other, driven by the sodium gradient. Lysophospholipids are phospholipids lacking one fatty acyl chain and are intermediates formed during digestion of dietary and biliary phospholipids. This activity is critical for lipid homeostasis and for the signaling roles of lysophospholipids such as lysophosphatidic acid (LPA), lysophosphatidylcholine (LPC), and lysophosphatidylinositol (LPI). Researchers study this term to understand how cells import and export bioactive lipids, how sodium-coupled transport influences membrane composition, and how dysregulation contributes to diseases including secretory diarrhea, polycystic kidney disease, and cardiac disorders. The symporter activity is also relevant to drug development, as modulating lysophospholipid levels can alter ion channel function and inflammatory responses.
lysophospholipid:sodium symporter activity At A Glance
| GO ID | GO:0051978 |
|---|---|
| GO term | lysophospholipid:sodium symporter activity |
| Ontology | molecular_function |
| Synonym | lysophospholipid transporter activity |
| Major function | Sodium-coupled transport of lysophospholipids across membranes |
| Substrates | Lysophospholipids such as lysophosphatidylcholine and lysophosphatidylinositol |
| Coupled ion | Sodium (Na+) |
| Directionality | Directed movement from one side of a membrane to the other |
| Biological context | Lipid digestion, absorption, and signaling |
What Is GO:0051978?
In simple terms, GO:0051978 describes a protein machine that uses sodium ions to push lysophospholipids across a cell membrane. The QuickGO definition states: Enables the directed movement of lysophospholipids from one side of a membrane to the other. A lysophospholipid is a phospholipid that lacks one of its fatty acyl chains; it is an intermediate formed during digestion of dietary and biliary phospholipids. This function is synonymous with lysophospholipid transporter activity and is classified under molecular_function.
Why Is lysophospholipid:sodium symporter activity Important in Cell Biology?
GO:0051978 is important because lysophospholipid transport directly influences the availability of bioactive lipids that regulate ion channels, transporters, and cell survival pathways. For example, lysophosphatidic acid modulates cyst growth in autosomal dominant polycystic kidney disease, and lysophosphatidylcholine augments cardiac late sodium currents, linking this transport activity to disease mechanisms. Understanding the symporter activity can reveal therapeutic targets for secretory diarrhea, where lysophospholipids and sodium transport are intertwined.
• Regulates cellular levels of lysophospholipids, which are signaling molecules in inflammation and cancer.
• Coupled to sodium gradient, linking lipid transport to electrolyte homeostasis.
• Modulates ion channels, including cardiac late sodium currents and calcium signaling.
• Implicated in secretory diarrhea through effects on NHE3 regulation.
• Contributes to polycystic kidney disease cyst growth via lysophosphatidic acid.
• Affects endothelial cell hyperpolarization and vascular function.
• Potential target for anti-apoptotic signaling through LPA2 receptor complexes.
• Required for dietary and biliary phospholipid digestion and absorption.
• Provides a mechanism for sodium-dependent lipid uptake in neuroblastoma cells.
• Offers a research entry point for CRISPR screens targeting lipid transporters.
Molecular Mechanism of lysophospholipid:sodium symporter activity
Substrate recognition and binding
In simple terms: The symporter first grabs a lysophospholipid molecule.
The symporter recognizes lysophospholipids such as lysophosphatidylcholine (LPC) and lysophosphatidylinositol (LPI) through specific binding pockets. Studies show that LPC and LPI elicit distinct ion signaling responses, indicating selective recognition. The lack of one fatty acyl chain in lysophospholipids creates a cone-shaped geometry that may fit a dedicated binding site.
Sodium coupling and conformational cycling
In simple terms: Sodium ions power the transport by changing the protein's shape.
Sodium binding to the symporter drives conformational changes that translocate the lysophospholipid across the membrane. This sodium-dependent mechanism is distinct from GPR55-dependent signaling, as LPI can inhibit Na+/Ca2+ exchanger independently of GPR55. The sodium gradient provides the energy for directed movement.
Membrane translocation and release
In simple terms: The lipid is flipped to the other side and released.
After translocation, the lysophospholipid is released into the opposite leaflet or extracellular space. This process contributes to the pool of lysophospholipids that can activate receptors like LPA2 or modulate NHE3 via NHERF proteins. The directed movement is essential for lipid asymmetry and signaling.
Regulation by calcium and cGMP
In simple terms: Other signals can speed up or slow down the symporter.
Elevated calcium and cGMP regulate NHE3 in a process that requires NHERF2 and NHERF3, and lysophosphatidic acid modulates this regulation. Similarly, LPC-induced calcium responses in neuroblastoma cells suggest that calcium signaling feedback can influence lysophospholipid transport. Peroxynitrite formation mediates LPC-induced augmentation of cardiac late sodium currents, linking oxidative stress to transport regulation.
Key Genes Involved in GO:0051978 lysophospholipid:sodium symporter activity
The following genes and proteins are functionally linked to lysophospholipid:sodium symporter activity or its downstream signaling, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC10A1 | Sodium-dependent bile acid transporter; may transport lysophospholipids | Potential symporter candidate for lipid uptake |
| SLC10A2 | Apical sodium-dependent bile acid transporter | Expressed in intestine; linked to lipid absorption |
| NHE3 (SLC9A3) | Sodium/hydrogen exchanger | Regulated by LPA and calcium; affects sodium transport |
| NHERF2 (SLC9A3R2) | Scaffold protein for NHE3 | Required for LPA-mediated NHE3 regulation |
| NHERF3 (PDZK1) | Scaffold protein for NHE3 | Necessary for acute regulation of NHE3 |
| LPAR2 | Lysophosphatidic acid receptor 2 | Mediates antiapoptotic signaling via supramolecular complexes |
| GPR55 | Lysophosphatidylinositol receptor | GPR55-dependent and -independent ion signaling |
| PKD1 | Polycystin-1 | Mutations cause ADPKD; LPA modulates cyst growth |
| PKD2 | Polycystin-2 | ADPKD-related; interacts with LPA signaling |
| SCN5A | Cardiac sodium channel | LPC augments late sodium current via peroxynitrite |
| NCX1 (SLC8A1) | Na+/Ca2+ exchanger | Inhibited by LPI and LPC independently of GPR55 |
| PLA2G4A | Phospholipase A2 | Generates lysophospholipids from phospholipids |
| ABCB4 | Phosphatidylcholine floppase | Biliary phospholipid secretion; source of lysophospholipids |
| LPCAT1 | Lysophosphatidylcholine acyltransferase | Reacylates LPC; balances lysophospholipid levels |
| ENPP2 | Autotaxin | Produces lysophosphatidic acid from LPC |
| LPAR1 | Lysophosphatidic acid receptor 1 | Mediates LPA effects on cyst growth |
| TRPV4 | Calcium-permeable channel | LPC-induced calcium responses in neuroblastoma |
How Is lysophospholipid:sodium symporter activity Regulated?
The activity of lysophospholipid:sodium symporters is regulated at multiple levels. Acute regulation by calcium and cGMP requires NHERF2 and NHERF3, which scaffold NHE3 and modulate its transport activity in response to lysophosphatidic acid. Oxidative stress, through peroxynitrite formation, mediates LPC-induced augmentation of cardiac late sodium currents, suggesting redox regulation of sodium-coupled transport. Additionally, GPR55-dependent and -independent pathways control ion signaling in response to lysophosphatidylinositol, indicating receptor-mediated feedback.
lysophospholipid:sodium symporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NHE3 (SLC9A3) | Secretory diarrhea | Intestinal epithelial KO cells |
| PKD1 | Polycystic kidney disease | Kidney organoids with point mutations |
| SCN5A | Cardiac arrhythmia | Cardiomyocytes overexpressing SCN5A |
| LPAR2 | Cancer apoptosis | Knockout cancer cell lines |
| GPR55 | Endothelial dysfunction | Endothelial cells with GPR55 KO |
Secretory diarrhea
Secretory diarrhea involves dysregulated sodium and chloride transport in the intestine. Lysophospholipids such as LPA modulate NHE3, a key sodium transporter, through NHERF2 and NHERF3, linking lysophospholipid:sodium symporter activity to diarrheal disease mechanisms.
Polycystic kidney disease
Lysophosphatidic acid is a modulator of cyst growth in autosomal dominant polycystic kidney disease. This suggests that lysophospholipid transport and signaling contribute to cystogenesis, making the symporter activity a potential therapeutic target.
Cardiac arrhythmias
LPC-induced augmentation of cardiac late sodium currents via peroxynitrite formation links lysophospholipid metabolism to arrhythmogenic conditions. The sodium symporter activity may influence the availability of LPC to modulate SCN5A.
Cancer and apoptosis
LPA2 receptor-mediated supramolecular complex formation regulates antiapoptotic effects, implicating lysophospholipid transport in cancer cell survival. Lysophospholipids also affect endothelial cell hyperpolarization, relevant to angiogenesis.
From lysophospholipid:sodium symporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X transport lysophospholipids? | Knockout cell model + lipid flux assay |
| Does point mutation alter sodium coupling? | Point-mutation knock-in cells |
| Where is the symporter localized? | Tagged knock-in with fluorescent tag |
| Does overexpression change signaling? | Overexpression stable cell line |
| Which genes regulate symporter activity? | CRISPR library screening |
| Can we rescue the phenotype? | Knock-in of wild-type allele |
How to Study the lysophospholipid:sodium symporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipid flux assay | Transport of labeled lysophospholipids | Symporter activity in KO cells |
| Patch-clamp | Sodium currents | Cardiac late sodium current |
| Calcium imaging | Intracellular Ca2+ changes | LPC responses in neuroblastoma |
| Western blot | Protein expression | Validation of KO/overexpression |
| Immunofluorescence | Subcellular localization | Tagged knock-in cells |
| RNA-seq | Transcriptional changes | Pathway analysis after KO |
| CRISPR screen | Gene essentiality for transport | Library screening |
| Co-immunoprecipitation | Protein-protein interactions | NHERF2/NHERF3 complexes |
Lipid flux assays
Radiolabeled or fluorescent lysophospholipids can be used to measure transport across membranes in cells with knockout or overexpression of candidate genes. This directly assesses symporter activity.
Electrophysiology
Patch-clamp and ion-selective electrodes can measure sodium currents and membrane potential changes in response to lysophospholipids, as shown for LPC-induced late sodium currents.
Calcium imaging
Fluorescent calcium indicators reveal lysophospholipid-induced calcium responses, as demonstrated in neuroblastoma SH-SY5Y cells.
Proteomics and interactomics
Affinity purification and mass spectrometry can identify proteins in supramolecular complexes with lysophospholipid receptors, such as LPA2 complexes.
How CRISPR Can Be Used to Study GO:0051978 lysophospholipid:sodium symporter activity
Knockout
CRISPR knockout of candidate symporter genes (e.g., SLC10A1, SLC10A2) can abolish lysophospholipid transport, allowing functional validation. Knockout of NHE3 or NHERF proteins can reveal their role in LPA-mediated regulation.
Point Mutation
Introducing point mutations in putative sodium-binding or substrate-binding residues can dissect the transport mechanism. For example, mutating SCN5A to mimic phosphorylation sites can test LPC effects on late sodium current.
Knock-in
Knock-in of tagged versions of symporter genes enables live-cell imaging and localization studies. Knock-in of disease-associated variants (e.g., PKD1 mutations) can model cyst growth in response to LPA.
Overexpression
Overexpression of lysophospholipid receptors or transporters can amplify signaling and transport, facilitating biochemical assays. Overexpression of GPR55 or LPAR2 can enhance LPI/LPA responses.
How EDITGENE Supports lysophospholipid:sodium symporter activity Research
Researchers studying lysophospholipid:sodium symporter activity-related genes often need to determine whether a candidate gene is causally involved in lipid transport, ion signaling, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for lysophospholipid:sodium symporter activity research.
Frequently Asked Questions About lysophospholipid:sodium symporter activity
What is GO:0051978?
GO:0051978 is the Gene Ontology term for lysophospholipid:sodium symporter activity, a molecular function that enables sodium-dependent transport of lysophospholipids across membranes.
What genes are involved in lysophospholipid:sodium symporter activity?
Genes such as SLC10A1, SLC10A2, NHE3, NHERF2, NHERF3, LPAR2, GPR55, and SCN5A have been linked to lysophospholipid transport or signaling.
How is lysophospholipid:sodium symporter activity regulated?
It is regulated by calcium, cGMP, and scaffolding proteins NHERF2 and NHERF3, as well as by oxidative stress via peroxynitrite.
What diseases are associated with lysophospholipid:sodium symporter activity?
Secretory diarrhea, polycystic kidney disease, cardiac arrhythmias, and cancer apoptosis have been associated with lysophospholipid signaling and transport.
What is the function of lysophospholipid:sodium symporter activity?
It transports lysophospholipids across membranes using the sodium gradient, influencing lipid signaling and ion channel function.
Which lysophospholipids are transported?
Lysophosphatidylcholine (LPC) and lysophosphatidylinositol (LPI) are examples of lysophospholipids that elicit biological responses.
How can I study lysophospholipid:sodium symporter activity in the lab?
Use lipid flux assays, electrophysiology, calcium imaging, and CRISPR knockout models to measure transport and signaling.
What are the research tools for GO:0051978?
CRISPR knockout, point mutation, knock-in, overexpression cell models, and library screening are key tools for studying this function.
Is lysophospholipid:sodium symporter activity linked to cancer?
Yes, LPA2 receptor-mediated antiapoptotic signaling involves lysophospholipid transport and signaling, relevant to cancer cell survival.
How does sodium couple to lysophospholipid transport?
Sodium binding provides the energy for conformational changes that translocate the lysophospholipid across the membrane.
Conclusion
GO:0051978, lysophospholipid:sodium symporter activity, is a critical molecular function that couples sodium gradients to the transport of bioactive lysophospholipids. Its roles in secretory diarrhea, polycystic kidney disease, cardiac arrhythmias, and cancer highlight its broad physiological and pathological importance. Continued research using CRISPR models and advanced assays will uncover the molecular identity of the symporter and its therapeutic potential.
References
- 1. Thiagarajah JR et al.. 2015. Secretory diarrhoea: mechanisms and emerging therapies.. Nat Rev Gastroenterol Hepatol 12(8):446-57 PMID: 26122478
- 2. Blazer-Yost BL et al.. 2011. Lysophosphatidic acid is a modulator of cyst growth in autosomal dominant polycystic kidney disease.. Cell Physiol Biochem 28(6):1255-64 PMID: 22179013
- 3. E S et al.. 2009. Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect.. J Biol Chem 284(21):14558-71 PMID: 19293149
- 4. Bondarenko AI et al.. 2017. GPR55 agonist lysophosphatidylinositol and lysophosphatidylcholine inhibit endothelial cell hyperpolarization via GPR-independent suppression of Na(+)-Ca(2+) exchanger and endoplasmic reticulum Ca(2+) refilling.. Vascul Pharmacol 89:39-48 PMID: 28064014
- 5. Li XH et al.. 2007. Characteristics of lysophosphatidylcholine-induced Ca2+ response in human neuroblastoma SH-SY5Y cells.. Life Sci 80(9):886-92 PMID: 17157326
- 6. Avula LR et al.. 2018. Both NHERF3 and NHERF2 are necessary for multiple aspects of acute regulation of NHE3 by elevated Ca(2+), cGMP, and lysophosphatidic acid.. Am J Physiol Gastrointest Liver Physiol 314(1):G81-G90 PMID: 28882822
- 7. Gautier M et al.. 2008. Peroxynitrite formation mediates LPC-induced augmentation of cardiac late sodium currents.. J Mol Cell Cardiol 44(2):241-51 PMID: 17961592
- 8. Bondarenko A et al.. 2010. GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells.. Br J Pharmacol 161(2):308-20 PMID: 20735417
